Financial Statements — PRFX
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Cash & Equivalents | 3.48 | 2.78 | 5.14 | 13.85 | 17.79 |
| Short-term Investments | -- | -- | 1.01 | -- | -- |
| Total Current Assets | 3.91 | 2.99 | 8.28 | 15.93 | 19.81 |
| Property, Plant & Equipment | 0.03 | 0.04 | 0.04 | 0.05 | 0.02 |
| Intangible Assets | 7.12 | -- | -- | -- | -- |
| Total Non-current Assets* | 7.25 | 0.12 | 0.04 | 0.05 | 0.02 |
| Total Assets | 11.16 | 3.11 | 8.32 | 15.99 | 19.84 |
| Total Current Liabilities | 2.46 | 4.89 | 1.10 | 0.55 | 0.61 |
| Total Non-current Liabilities* | 0.26 | 0.26 | 0.25 | 0.24 | 0.22 |
| Total Liabilities | 2.72 | 5.15 | 1.34 | 0.79 | 0.83 |
| Retained Earnings | (58.77) | (54.68) | (37.01) | (27.24) | (20.22) |
| Total Stockholder Equity | 8.44 | (2.04) | 6.97 | 15.20 | 19.01 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Research & Development | 0.28 | 11.41 | 2.70 | 1.42 | 1.73 |
| Selling, General & Admin | 1.92 | 1.50 | 1.97 | 2.09 | 1.97 |
| Operating Income | (2.37) | (12.91) | (4.67) | (3.52) | (3.70) |
| Net Income | (2.32) | (12.82) | (4.49) | (3.52) | (3.74) |
| Basic EPS | (1.09) | (3.12) | (4.12) | (0.33) | -- |
| Diluted EPS | (1.09) | (3.12) | (4.12) | (0.33) | -- |
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Operating Cash Flow | (1.98) | (8.64) | (3.95) | (2.70) | (3.42) |
| Capital Expenditures | 0.00 | 0.01 | 0.00 | 0.00 | 0.02 |
| Free Cash Flow* | (1.98) | (8.66) | (3.95) | (2.70) | (3.44) |
| Investing Cash Flow | (0.05) | (0.01) | 5.00 | -0.00 | (0.02) |
| Financing Cash Flow | 1.25 | 3.41 | 0.00 | 0.00 | 5.55 |
* Derived from reported values
